Menu

1 / 8

FDA tells GLP-1 makers to warn of potential vision loss side effect

Business - Latest - Google News·6 days ago
#Fqf03wvx
Reading 0:00
15s threshold

Democracy Dies in Darkness

The agency is requiring GLP-1 manufacturers to warn the drugs can increase risk of “eye stroke.”

November 9, 2026 at 3:50 p.m. EST52 minutes ago

(The Washington Post illustration; iStock)

The Food and Drug Administration announced Monday that it is requiring manufacturers of GLP-1 medications to warn that they can increase the risk of vision loss.

The warning applies to all GLP-1 medications, including popular weight loss drugs like Ozempic and Wegovy.